The rules of engagement for patient and caregiver communities have changed. Once off limit to industry insiders, patient communities are now opening their doors to pharma. What does this mean for pharma companies and how do you shift your strategy? Jack DeManche, Director of Digital Strategy at PRECISIONeffect, chats with MM+M and other industry leaders about the catalysts driving the shift towards greater community engagement, insights into the evolving landscape of patient involvement, and nuanced approaches to fostering collaborations.
